BRIEF published on 11/13/2024 at 08:05, 8 days 6 hours ago PWO Group Maintains Steady Progress Despite Challenges in 2024 Business Expansion Market Opportunities PWO Group 2024 Performance Resilience Strategy
PRESS RELEASE published on 11/13/2024 at 08:00, 8 days 6 hours ago PWO Group on track in the nine-month period of 2024 PWO Group reports strong performance in 2024 nine-month period, confirming forecasts and exceeding expectations. Focus on new business and future growth strategies Growth Strategy Financial Performance 2024 PWO Group New Business
BRIEF published on 08/09/2024 at 09:23, 3 months 12 days ago PWO Group Maintains Positive Trajectory in the First Half of 2024 Expansion Revenue EBIT Free Cash Flow Mobility Industry
PRESS RELEASE published on 08/09/2024 at 09:18, 3 months 12 days ago PWO Group stays on track for success in the first half of the year PWO Group reports strong financial performance in the first half of 2024, with revenue and EBIT exceeding prior-year figures. Expectations for free cash flow upgraded, new business growing Financial Performance Revenue Free Cash Flow PWO Group New Business
BRIEF published on 07/18/2024 at 17:11, 4 months 2 days ago PWO Group Expands Mexican Locations Sustainability Investment PWO Group Mexico Expansion Tool Logistics
PRESS RELEASE published on 07/18/2024 at 17:06, 4 months 2 days ago PWO Group expands Mexican locations further PWO Group is expanding its Mexican locations, doubling tool logistics capacity by investing EUR 1 million in new space and equipment. This expansion aims to optimize production processes and enhance competitiveness Expansion PWO Group Tool Logistics Mexican Locations Production Processes
BRIEF published on 06/07/2024 at 14:20, 5 months 13 days ago PWO Annual General Meeting Approves All Agenda Items with Large Majority Annual General Meeting Strategic Development 2023 Financial Year Dividend PWO AG
PRESS RELEASE published on 06/07/2024 at 14:15, 5 months 14 days ago PWO Annual General Meeting approves all agenda items with a large majority PWO AG Annual General Meeting approves all agenda items with increased dividend and confirms 2024 forecast. CEO highlights strong performance in 2023 and future growth strategies Annual General Meeting Dividend Increase 2024 Forecast PWO AG Global Market Position
BRIEF published on 05/28/2024 at 16:12, 5 months 23 days ago PWO AG Continues Growth with New Site in Serbia Expansion Engineering PWO AG Production Serbia
PRESS RELEASE published on 05/28/2024 at 16:07, 5 months 23 days ago PWO AG continues growth PWO AG continues growth with new engineering and production site in Serbia. First series production expected by end of 2025. Strengthening market position and creating jobs Growth Engineering PWO AG Serbia Mobility Industry
Published on 11/21/2024 at 14:00, 18 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 18 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 18 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 48 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 43 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 3 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 20 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 58 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 33 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 33 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
